These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15760052)

  • 21. Preparation and evaluation of talc agglomerates obtained by wet spherical agglomeration as a substrate for coating.
    Jadhav NR; Pawar AP; Paradkar AR
    Pharm Dev Technol; 2011 Apr; 16(2):152-61. PubMed ID: 20105058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melt solidification technique: incorporation of higher wax content in ibuprofen beads.
    Kamble R; Maheshwari M; Paradkar A; Kadam S
    AAPS PharmSciTech; 2004 Oct; 5(4):e61. PubMed ID: 15760058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
    Vilhelmsen T; Eliasen H; Schaefer T
    Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibuprofen agglomerates preparation by phase separation.
    Jbilou M; Ettabia A; Guyot-Hermann AM; Guyot JC
    Drug Dev Ind Pharm; 1999 Mar; 25(3):297-305. PubMed ID: 10071822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characteristics of microcapsules containing enoxacin by one continuous process of agglomeration and microencapsulation.
    Ueda M; Nakamura Y; Makita H; Kawashima Y
    J Microencapsul; 1993; 10(2):171-80. PubMed ID: 8331491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and
    Ravouru N; Penjuri SCB; Damineni S; Muni RL; Poreddy SR
    Turk J Pharm Sci; 2018 Apr; 15(1):7-15. PubMed ID: 32454634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique.
    Nokhodchi A; Maghsoodi M
    AAPS PharmSciTech; 2008; 9(1):54-9. PubMed ID: 18446461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
    Soares FL; Carneiro RL
    J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the effect of some additives on the efficiency of binder liquid in wet agglomeration of crystals.
    Maghsoodi M; Nabizadeh H; Nokhodchi A
    Pharm Dev Technol; 2017 Sep; 22(6):827-835. PubMed ID: 27387408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound-assisted preparation of novel ibuprofen-loaded excipient with improved compression and dissolution properties.
    Gandhi P; Patil S; Aher S; Paradkar A
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1553-63. PubMed ID: 26858024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
    Pawar AA; Chen DR; Venkataraman C
    Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Development of Crystallo-co-agglomerates of Ritonavir for the Improvement of Physicochemical Properties.
    Mahajan NM; Malghade AD; Dumore NG; Thenge RR
    Turk J Pharm Sci; 2018 Dec; 15(3):248-255. PubMed ID: 32454667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of ibuprofen crystallized under various conditions: a comparative study.
    Rasenack N; Müller BW
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1077-89. PubMed ID: 12455467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shear-induced APAP de-agglomeration.
    Llusa M; Levin M; Snee RD; Muzzio FJ
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1487-95. PubMed ID: 19929208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation.
    Deshkar SS; Borde GR; Kale RN; Waghmare BA; Thomas AB
    Int J Pharm Investig; 2017; 7(4):164-173. PubMed ID: 29692975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
    Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microwave generated solid dispersions containing Ibuprofen.
    Moneghini M; Bellich B; Baxa P; Princivalle F
    Int J Pharm; 2008 Sep; 361(1-2):125-30. PubMed ID: 18573321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.